arrow
J

Justin A. Ezekowitz

canadian vigour centre university of alberta
H指数:87
被引数:5.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MAGGIC and PREDICT-HF Models in the VICTOR Trial: Do Traditional Risk Scores Still Work in Well-Treated Ambulatory Patients with HFrEF?

MAGGIC和PREDICT-HF模型在VICTOR试验中:传统风险评分在治疗良好的HFrEF门诊患者中是否仍然有效?

2026-09-210
PRE
Mortality benefit and lifetime survival gains with vericiguat in HFrEF: Bayesian and actuarial analyses of the VICTOR trial

维利卡格在HFrEF中的死亡率效益和终身生存获益:VICTOR试验的贝叶斯和精算分析

2026-09-160
OAAI
Efficacy of vericiguat by background guideline-directed medical therapy in the VICTOR trial

在VICTOR试验中,vericiguat在背景指南导向药物治疗下的疗效

2026-09-080
OAAI
Effectiveness and safety of sodium-glucose cotransporter-2 inhibitor initiation in sacubitril-valsartan users with heart failure: a population-based cohort study

钠-葡萄糖协同转运蛋白-2抑制剂在沙库巴曲缬沙坦使用者中的起始应用效果与安全性:一项基于人群的队列研究

2026-05-070
OAAI
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

勘误:加拿大心血管学会/加拿大心力衰竭学会2025年射血分数轻度降低(LVEF > 40%)心力衰竭药物治疗指南更新

2026-01-060
OAAI
Corrigendum to Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%).

勘误:加拿大心血管学会/加拿大心力衰竭学会2025年射血分数降低型心力衰竭(LVEF > 40%)药物治疗管理指南更新。

2025-12-230
PRE
The Canadian Heart Failure Society (CHFS) Workforce Committee Report 2024: Addressing the Challenges Facing the Heart Failure Physicians Workforce in Canada CHFS 2024 Heart Failure Workforce Report

加拿大心力衰竭学会(CHFS)工作组委员会报告2024:应对加拿大心力衰竭医师工作队伍面临的挑战 CHFS 2024 心力衰竭工作队伍报告

2025-12-040
OAAI
The Alternative Imaging Modalities in Ischemic Heart Failure (AIMI-HF) Trial―IMAGE HF Project 1A

缺血性心力衰竭中的替代成像模式(AIMI-HF)试验——IMAGE HF项目1A

2025-11-010
OA
Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of CRD-740, a PDE9 Inhibitor, in Chronic Heart Failure

II期、随机、双盲、安慰剂对照研究,评估CRD-740(一种PDE9抑制剂)在慢性心力衰竭中的应用

2025-10-310
PRE
Diet and Clinical Outcomes in a Heart Failure Population

饮食与心力衰竭人群的临床结局

2025-10-290
PRE
Canadian Cardiovascular Society/Canadian Heart Failure Society 2025 Guideline Update for Pharmacologic Management of Heart Failure With Nonreduced Ejection Fraction (LVEF > 40%)

加拿大心血管学会/加拿大心力衰竭学会2025年射血分数轻度降低(LVEF > 40%)心力衰竭的药物治疗指南更新

2025-10-180
PRE
Artificial intelligence-based echocardiographic assessment for monitoring disease progression in transthyretin cardiac amyloidosis

基于人工智能的心脏超声评估在监测甲状腺素转运蛋白心脏淀粉样变性疾病进展中的应用

2025-10-160
OAAI